We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Dalbavancin: a new option for systemic treatment of Gram-positive endogenous endophthalmitis?
- Authors
Hamon, Antoine; Benaboud, Sihem; Anjou, Mickael; Thoreau, Benjamin; Dedieu, Daphné; Brezin, Antoine; Bournaud, Léo Froelicher; Tazi, Asmaa; Charlier, Caroline; Canouï, Etienne
- Abstract
This article discusses a case study of a 33-year-old patient with endogenous endophthalmitis, a rare infection of the internal eye. The patient had a history of intravenous drug use and presented with eye pain, fever, and visual impairment. The infection was caused by methicillin-susceptible Staphylococcus aureus (MSSA), and the patient was treated with a combination of intravenous antibiotics and intravitreal injections. The article also explores the use of dalbavancin, a new antibiotic, in the treatment of endogenous endophthalmitis. The study found that dalbavancin had good penetration into the eye and could be a potential option for systemic therapy. However, further research is needed to fully understand its pharmacokinetics in this context.
- Subjects
ENDOPHTHALMITIS; INTRAVITREAL injections; EYE pain; EYE infections; FEVER; STAPHYLOCOCCUS aureus
- Publication
Journal of Antimicrobial Chemotherapy (JAC), 2023, Vol 78, Issue 12, p3005
- ISSN
0305-7453
- Publication type
Article
- DOI
10.1093/jac/dkad308